Radiation plus chemotherapy as adjuvant therapy for rectal cancer

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 2, 2002, Pages 267-282

  Minsky, Bruce D ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Adjuvant therapy; Combined modality therapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LEVAMISOLE; OXALIPLATIN; RALTITREXED; UFT; ANTINEOPLASTIC AGENT;

ANUS SPHINCTER; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; HUMAN; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROGNOSIS; RADIATION DOSE; RECTUM CANCER; RECTUM SURGERY; REVIEW; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; EVIDENCE BASED MEDICINE; RECTUM TUMOR; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HEMATOLOGIC DISEASE; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; RECTUM RESECTION; SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036548869     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0285     Document Type: Article

References (107)

1. Minsky B D Mies C Recht A et al. Resectable adenocarcinoma of the rectosigmoid and rectum: 1. Patterns of failure and survival Cancer 61 1988 1408-1416
2. Gunderson L L Sosin H Areas of failure found at reoperation (second or symptomatic look) following 'curative surgery' for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy Cancer 34 1974 1278-1292
3. Minsky B D Conti J A Huang Y Knopf K The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer Journal of Clinical Oncology 13 1995 1409-1416
4. Fisher B Wolmark N Rockette H et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01 Journal of the National Cancer Institute 80 1988 21-29
5. Wolmark N Weiand H S Hyams D M et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project protocol R-02 Journal of the National Cancer Institute 92 2000 388-396
6. Willett C G Tepper J E Kaufman D S et al. Adjuvant postoperative radiation therapy for rectal adenocarcinoma American Journal of Clinical Oncology 15 1992 371-375
7. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. New England Journal of Medicine 310 1984 737-743
8. Krook J E Moertel C G Gunderson L L et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma New England Journal of Medicine 324 1991 709-715
9. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. Journal of the American Medical Association 264 1990 1444-1450
10. Miller R C Martenson J A Sargent D J et al. Acute diarrhea during rectal adjuvant postoperative pelvic radiation therapy (RT) with or without 5-fluorouracil: a detailed analysis of toxicity from a randomized North Central Cancer Treatment Group study American Society of Clinical Oncology 17 1998 279a
11. Minsky B D Cohen A M Enker W E et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the pre-operative approach Journal of Clinical Oncology 10 1992 1218-1224
12. Sauer R Fietkau R Wittekind C et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer Strahlentherapie Onkologie 177 2001 173-181
13. Roh M S Petrelli N Weiand H et al. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03) American Society of Clinical Oncology 20 2001 123a
14. Johnston P G Fisher E R Rockette H E et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer Journal of Clinical Oncology 12 1994 2640-2647
15. Elwell A Xoing Y P Chang M et al. p53, p21 and thymidylate synthase (TS) protein expression: associations with recurrence in stage II and III rectal cancer American Society of Clinical Oncology 16 1997 258
16. Tepper J E O'Connell M J Petroni G R et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114 Journal of Clinical Oncology 15 1997 2030-2039
17. Tepper J E O'Connel M J Niedzwiecki D et al. Final report of INT 0114 - adjuvant therapy in rectal cancer: analysis by treatment, stage and gender American Society of Clinical Oncology 20 2001 123a
18. O'Connell M J Laurie J A Kahn M et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer Journal of Clinical Oncology 16 1998 295-300
19. Haller D G Catalano P J Macdonald J S et al. Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: preliminary results of INT-0089 American Society of Clinical Oncology 15 1996 211
20. Willett C G Badizadegan K Ancukiewicz M Shellito P C Prognostic factors in stage T3N0 rectal cancer. Do all patients require post-operative pelvic irradiation and chemotherapy? Diseases of the Colon and Rectum 42 1999 167-173
21. Willett C G Lewandrowski K Donnelly S et al. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 69 1992 1651-1655
22. Skibber J M Hoff P M Minsky B D Cancer of the rectum. In DeVita V T Hellman S & Rosenberg S A (Eds.), Cancer: Principles and Practice of Oncology 2001 1271-1318 Lippincott, Williams and Wilkens Philadelphia
23. Kim N K Kim M J Yun S H et al. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer Diseases of the Colon and Rectum 42 1999 770-775
24. Heriot A G Grundy A Kumar D Preoperative staging of rectal carcinoma British Journal of Surgery 86 1999 17-28
25. Gualidi G F Casciani E Guadalaxara A et al. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging. Comparison with histologic findings Diseases of the Colon and Rectum 43 2000 338-345
26. Beets-Tan R GH Beets G L Vliegen R FA et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery Lancet 357 2001 497-504
27. Adams D R Blatchford G J Lin K M et al. Use of preoperative ultrasound staging for treatment of rectal cancer Diseases of the Colon and Rectum 42 1999 159-166
28. Milsom J W Czyrko C Hull T L et al. Preoperative biopsy of pararectal lymph nodes in rectal cancer using endoluminal ultrasonography Diseases of the Colon and Rectum 37 1994 364-368
29. Guillem J G Puig-La Calle J Akhurst T et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography Diseases of the Colon and Rectum 43 2000 18-24
30. Whiteford M H Whiteford H M Yee L F et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum Diseases of the Colon and Rectum 53 2000 759-770
31. Flamen P Stroobants S van Cutsem E et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer Journal of Clinical Oncology 17 1999 894-901
32. Barbaro B Schulsinger A Valentini V et al. The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy International Journal of Radiation Oncology, Biology and Physics 43 1999 1043-1047
33. Gavioli M Bagni A Piccagli I et al. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer Diseases of the Colon and Rectum 43 2000 1075-1083
34. Minsky B D Multidisciplinary management of resectable rectal cancer Oncology 10 1996 1701-1714
35. Chari R S Tyler D S Anscher M S et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Annals of Surgery 221 1995 778-787
36. Grann A Feng C Wong D et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma International Journal of Radiation Oncology, Biology and Physics 49 2001 987-995
37. Stryker S J Kiel K D Rademaker A et al. Preoperative 'chemoradiation' for stages II and II rectal carcinoma Archives of Surgery 131 1996 514-519
38. Ngan S YK Burmeister B H Fisher R et al. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a phase II trial for the Trans-Tasman radiation oncology group International Journal of Radiation Oncology, Biology and Physics 50 2001 883-887
39. Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable, locally advanced rectal cancer. Lancet 348 1996 1605-1609
40. Glimelius B Isacson U Jung B Pahlman L Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment International Journal of Radiation Oncology, Biology and Physics 37 1997 281-287
41. Cedermark B Johansson H Rutqvist L E Wilking N The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma Cancer 75 1995 2269-2275
42. Boulis-Wassif S Gerard A Loygue J et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery Cancer 53 1984 1811-1818
43. Cedermark B The Stockholm II trial on preoperative short term radiotherapy in operable rectal carcinoma - a prospective randomized trial American Society of Clinical Oncology 13 1994 198
44. Camma C Giunta M Fiorica F et al. Preoperative radiotherapy for resectable rectal cancer. A meta-analysis Journal of the American Medical Association 284 2000 1008-1015
45. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancrer: a systematic overview of 22 randomized trials involving 8507 patients. Lancet 358 2001 1291-1304
46. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. New England Journal of Medicine 336 1997 980-987
47. Kapiteijn E Marijnen C A M Nagtegaal I D et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer New England Journal of Medicine 345 2001 638-646
48. Holm T Rutqvist L E Johansson H Cedermark B Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors British Journal of Surgery 83 1996 964-968
49. Holm T Singnomklao T Rutqvist L E Cedermark B Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials Cancer 78 1996 968-976
50. Marijnen C A M Kapiteijn E van de Velde C J H et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer, Journal of Clinical Oncology (in press).
51. Graf W Dahlberg M Osman M M et al. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients Radiotherapy and Oncology 43 1997 133-137
52. Marijnen C A M Nagtegaal I D Kranenbarg E K et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients Journal of Clinical Oncology 19 2001 1976-1984
53. Francois Y Nemoz C J Baulieux J et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial Journal of Clinical Oncology 17 1999 2396-2402
54. Sauer R Fietkau R Martus P et al. Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer - first results of the German multicenter phase-III trial International Journal of Radiation Oncology, Biology and Physics 48 2000 119
55. Wagman R Minsky B D Cohen A M et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long term follow-up International Journal of Radiation Oncology, Biology and Physics 42 1998 51-57
56. Rouanet P Fabre J M Dubois J B et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results Annals of Surgery 221 1995 67-73
57. Hyams D M Mamounas E P Petrelli N et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol R0-3 Diseases of the Colon and Rectum 40 1997 131-139
58. Valentini V Coco C Cellini N et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation International Journal of Radiation Oncology, Biology and Physics 40 1998 1067-1075
59. Grann A Feng C Wong D et al. Pre-op combined modality therapy (CMT) for uT3 rectal cancer International Journal of Radiation Oncology, Biology and Physics 49 2001 987-995
60. Maghfoor I Wilkes J Kuvshinoff B et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer American Society of Clinical Oncology 16 1997 274
61. Janjan N A Crane C Feig B W et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer American Journal of Clinical Oncology 24 2001 107-112
62. Read T E McNevin M S Gross E KM et al. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity Diseases of the Colon and Rectum 44 2001 513-522
63. Mohiuddin M Hayne M Regine W F et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers International Journal of Radiation Oncology, Biology and Physics 48 2000 1075-1080
64. Onaitis M W Noone R B Hartwig M et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience Annals of Surgery 233 2001 778-785
65. Grumann M M Noack E M Hoffman I A Schlag P M Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer Annals of Surgery 233 2001 149-156
66. Kollmorgen C F Meagher A P Pemberton J H et al. The long term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function Annals of Surgery 220 1994 676-682
67. Luna-Perez P Segura J Alvarado I et al. Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy Annals of Surgical Oncology 7 2000 727-731
68. Villafranca E Okruzhnov Y Dominguez M A et al. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer Journal of Clinical Oncology 19 2001 1779-1786
69. Esposito G Pucciarelli S Alaggio R et al. p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer Annals of Surgical Oncology 8 2001 311-318
70. Adell G Sun X F Olle S et al. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer Radiotherapy and Oncology 51 1999 169-174
71. Adell G CE Zhang H Evertsson S et al. Apoptosis in rectal cancer. Prognosis and recurrence after preoperative radiotherapy Cancer 91 2001 1870-1875
72. Adell G Zhang H Jansson A et al. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer International Journal of Radiation Oncology, Biology and Physics 50 2001 659-663
73. Habr-Gama A Santinho B de Souza P M et al. Low rectal cancer. Impact of radiation and chemotherapy on surgical treatment Diseases of the Colon and Rectum 41 1998 1087-1096
74. Rossi B M Nakagawa W T Noraes P E Filho W D J Lopes A Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial Annals of Surgical Oncology 5 1998 113-118
75. Ahmad N R Nagle D A Preoperative radiation therapy followed by local excision Seminars inRadiation Oncology 8 1998 36-38
76. MacFarlane J K Ryall R D Heald R J Mesorectal excision for rectal cancer Lancet 341 1993 457-460
77. Leong A P K Selective total mesorectal excision for rectal cancer Diseases of the Colon and Rectum 43 2000 1237-1240
78. Haas-Kock D F M Baeten C GMI Jager J J et al. Prognostic significance of radial margins of clearance in rectal cancer British Journal of Surgery 83 1996 781-785
79. Enker W E Thaler H T Cranor M L Polyak T Total mesorectal excision in the operative treatment of carcinoma of the rectum Journal of the American College of Surgeons 181 1995 335-345
80. Arenas R B Fichera A Mhoon D Michelassi F Total mesenteric excision in the surgical treatment of rectal cancer. A prospective study Archives of Surgery 133 1998 608-612
81. Havenga K Enker W E Norstein J et al. Improved survival and local control after total mesorectal excision or D3 lymphadnectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients European Journal of Surgical Oncology 25 1999 368-374
82. Aitken R J Mesorectal excision for rectal cancer British Journal of Surgery 83 1996 214-216
83. Carlsen E Schlichting E Guldvog I et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer British Journal of Surgery 85 1998 526-529
84. Poon R T P Chu K W Ho J W C et al. Prospective evaluation of selective defunctioning stoma for low anterior resection with total mesorectal excision World Journal of Surgery 23 1999 463-468
85. Nesbakken A Nygaard K Lunole O C Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer British Journal of Surgery 88 2001 400-404
86. Dahlberg M Glimelius B Pahlman L Changing strategy for rectal cancer is associated with improved outcome British Journal of Surgery 86 1999 379-384
87. Botwood N James R Vernon C et al. A phase I study of 'Tomudex' (raltitrexed) with radiotherapy (RT) as adjuvant treatment in patients (pt) with operable rectal cancer American Society of Clinical Oncology 17 1998 277a
88. Minsky B D UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review International Journal of Cancer (Radiation Oncology Investigations) 96 2001 1-10
89. Fernandez-Martos C Aparicio J Bosch C et al. Preoperative therapy (PT) with oral uracil and tegafur (UFT) and concomitant irradiation (RT) in operable rectal cancer (RC). Preliminary results of a multicenter phase II study American Society of Clinical Oncology 20 2001 148a
90. Valentini V Morganti A G Luzi S et al. Chemoradiation with raltitrexed (Tomudex) and oxaliplatin in preoperative treatment of stage II/III resectable rectal cancer: a dose finding study American Society of Clinical Oncology 20 2001 131a
91. Ryan D P Rectal cancer: integrating oxaliplatin into chemoradiation studies Oncology 14 2001 38-42
92. Freyer G Bossard N Romestaing P et al. Addition of oxaliplatin to continuous infusion fluorouracil, I-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial Journal of Clinical Oncology 19 2001 2433-2438
93. Mitchell E P Anne P Fry R et al. Combined modality therapy of locally advanced or recurrent adenocarcinoma of the rectum: report of a phase I trial of chemotherapy (CT) with CPT-11, 5-FU and concomitant irradiation (RT) American Society of Clinical Oncology 20 2001 131a
94. Klautke G Kirchner R Hopt U et al. Continuous infusion of 5-FU and weekly irinotecan with concurrent radiotherapy as neoadjuvant treatment for locally advanced or recurrent rectal cancer American Society of Clinical Oncology 20 2001 140a
95. Dunst J Reese T Frings S Phase I study of Capecitabine combined with standard radiotherapy in patients with rectal cancer American Society of Clinical Oncology 19 2000 256a
96. Reese T Tanner J Frings S et al. Capecitabine combined with simultaneous radiotherapy in rectal cancer: a phase I study International Journal of Radiation Oncology, Biology and Physics 48 2000 120
97. Battermann J J Results of d + T fast neutron irradiation on advanced tumors of the bladder and rectum International Journal of Radiation Oncology, Biology and Physics 8 1982 2159-2164
98. van der Zee J Gonzalez D G van Rhoon G C et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicenter trial Lancet 355 2000 1119-1125
99. Rhomberg W Eiter H Hergan K Schneider B Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane International Journal of Radiation Oncology, Biology and Physics 30 1994 419-425
100. Volter V Stupp R Matter M et al. Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in rectal carcinoma American Society of Clinical Oncology 20 2001 126b
101. Martenson J A Hyland G Moertel C G et al. Olsalizine is contraindicated during pelvic radiation therapy: results of a double-blind randomized clinical trial International Journal of Radiation Oncology, Biology and Physics 35 1996 299-303
102. Resbeut M Marteau P Cowen D et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis Radiotherapy and Oncology 44 1997 59-63
103. Koelbl O Richter S Flentje M Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model International Journal of Radiation Oncology, Biology and Physics 45 1999 1193-1198
104. Tait D M Nahum A E Meyer L C et al. Acute toxicity in pelvic radiotheraphy; a randomised trial of conformal versus conventional treatment Radiotherapy and Oncology 42 1997 121-136
105. Wiggenraad R Tamminga R Blok P et al. The prognostic significance of P53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy International Journal of Radiation Oncology, Biology and Physics 41 1998 29-35
106. Nicholl I D Dunlop M G Molecular markers of prognosis in colorectal cancer Journal of the National Cancer Institute 91 1999 1267-1269
107. O'Connell M J Martenson J A Weiand H S et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery New England Journal of Medicine 331 1994 502-507